Page last updated: 2024-12-05

formal glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID12586
CHEMBL ID3187281
CHEBI ID87597
MeSH IDM0056890

Synonyms (60)

Synonym
ethylene glycol, formal
646-06-0
glycolformal
glycol formal
einecs 211-463-5
1,3-dioxole, dihydro-
1,3-dioxolan
dioxolan [czech]
1,3-dioxacyclopentane
ethylene glycol formal
ccris 4912
hsdb 5737
un1166
formal glycol
glycol methylene ether
dioxolane
1,3-dioxolane ,
inchi=1/c3h6o2/c1-2-5-3-4-1/h1-3h
1,3-dioxolane, anhydrous, contains ~75 ppm bht as inhibitor, 99.8%
D0861
A834826
NCGC00248143-01
1,3-dioxalane
NCGC00254601-01
dtxsid4027284 ,
cas-646-06-0
dtxcid107284
tox21_300693
ec 211-463-5
unii-y57rbg19jl
y57rbg19jl ,
dioxolane [un1166] [flammable liquid]
ethylene glycol methylene ether
formaldehyde ethylene acetal
FT-0606705
1,3-dioxolane, stabilized
AKOS015856096
elcotal dx
dioxolane [inci]
dioxolane, 1,3-
1,3-dioxolane [hsdb]
5-crown-2
[1,3]dioxolane
[1,3]-dioxolane
1,3 dioxolane
J-503936
chebi:87597 ,
CHEMBL3187281
mfcd00003207
1,3-dioxolane, >=99.5%
1,3-dioxolane, reagentplus(r), contains ~75 ppm bht as inhibitor, 99%
D89731
Q2234483
1,3-dioxlane
1,3-dioxlane, 99.8%,with molecular sieves, stabilized with bht, water
1,3-dioxlane, 99.5%, contains ~75 ppm bht as stabilizer
1,3-dioxolane (stabilized with bht)
D5539
1,3-dioxolane 100 microg/ml in acetonitrile
25067-64-5

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" administration of trioxane produced no chromosomal damage resulting in erythrocyte micronucleus formation, even at highly toxic doses."( Genotoxic effects of dioxolane and trioxane in mice evaluated by the micronucleus test.
DziubaƂtowska, E; Kowalski, Z; Przybojewska, B, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dioxolane
cyclic acetalAn acetal in the molecule of which the acetal carbon and one or both oxygen atoms thereon are members of a ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency34.23000.000817.505159.3239AID1159527; AID1159531
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (98)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (22.45)18.7374
1990's18 (18.37)18.2507
2000's26 (26.53)29.6817
2010's30 (30.61)24.3611
2020's2 (2.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.13 (24.57)
Research Supply Index4.61 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.01%)6.00%
Case Studies1 (1.01%)4.05%
Observational0 (0.00%)0.25%
Other97 (97.98%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]